79 related articles for article (PubMed ID: 21284048)
1. Prognostic factors in patients with high-risk locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy.
Feinstein TM; Lai SY; Lenzner D; Gooding W; Ferris RL; Grandis JR; Myers EN; Johnson JT; Heron DE; Argiris A
Head Neck; 2011 Mar; 33(3):318-23. PubMed ID: 21284048
[TBL] [Abstract][Full Text] [Related]
2. Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database.
Jayaprakash V; Merzianu M; Warren GW; Arshad H; Hicks WL; Rigual NR; Sullivan MA; Seshadri M; Marshall JR; Cohan DM; Zhao Y; Singh AK
Head Neck; 2014 May; 36(5):694-701. PubMed ID: 23606370
[TBL] [Abstract][Full Text] [Related]
3. Outcomes and prognostic factors in modern era management of major salivary gland cancer.
Jegadeesh N; Liu Y; Prabhu RS; Magliocca KR; Marcus DM; Higgins KA; Vainshtein JM; Trad Wadsworth J; Beitler JJ
Oral Oncol; 2015 Aug; 51(8):770-7. PubMed ID: 26033470
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant Radiotherapy for Major Salivary Gland Malignancies: Impact on Locoregional Control and Survival Outcomes.
Katano A; Yamashita H
In Vivo; 2023; 37(6):2792-2795. PubMed ID: 37905628
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in surgically treated malignant salivary gland tumors.
Hofmann E; Priebe J; Rieke DT; Doll C; Coordes A; Olze H; Hofmann VM; Heiland M; Beck-Broichsitter B
Oral Oncol; 2023 Sep; 144():106484. PubMed ID: 37421674
[TBL] [Abstract][Full Text] [Related]
6. Is radical radiotherapy with/without surgery an effective treatment in the lymphoepithelial carcinoma of the salivary gland？.
Niu X; Liu P; Wang X; Hu C
BMC Cancer; 2023 Oct; 23(1):968. PubMed ID: 37828474
[TBL] [Abstract][Full Text] [Related]
7. Patterns and Trends in Adjuvant Therapy for Major Salivary Gland Cancer.
Patel AM; Haleem A; Choudhry HS; Povolotskiy R; Roden DF
Otolaryngol Head Neck Surg; 2024 Jul; 171(1):155-171. PubMed ID: 38482915
[TBL] [Abstract][Full Text] [Related]
8. Timing of postoperative radiation therapy for major salivary gland cancers.
Yan F; Liu JC; Shulman R; Galloway TJ; Ridge JA; Yao CMKL
Head Neck; 2024 Jun; ():. PubMed ID: 38864240
[TBL] [Abstract][Full Text] [Related]
9. Intraparotid node metastasis affects the long-term survival of patients with resectable recurrent parotid gland carcinoma.
Song Y; He Y; Li H; Zhao L; Liu Y; Liu S
Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5547-5555. PubMed ID: 37493846
[TBL] [Abstract][Full Text] [Related]
10. The evolving landscape of salivary gland tumors.
Steuer CE; Hanna GJ; Viswanathan K; Bates JE; Kaka AS; Schmitt NC; Ho AL; Saba NF
CA Cancer J Clin; 2023; 73(6):597-619. PubMed ID: 37490348
[TBL] [Abstract][Full Text] [Related]
11. Postoperative Chemoradiotherapy versus Radiotherapy Alone in Major Salivary Gland Cancers: A Stratified Study Based on the External Validation of the Distant Metastasis Risk Score Model.
Yan W; Huang L; Jiang J; Shen C; Ou X; Hu C
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428676
[TBL] [Abstract][Full Text] [Related]
12. Estimating survival after salvage surgery for recurrent salivary gland cancers: Systematic review.
Mannelli G; Comini LV; Sacchetto A; Santoro R; Spinelli G; Bonomo P; Desideri I; Bossi P; Orlandi E; Alderotti G; Franchi A; Palomba A; Eccher A; Marchioni D; Nocini R; Piazza C; Molteni G
Head Neck; 2022 Aug; 44(8):1961-1975. PubMed ID: 35441406
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant treatment for high-risk salivary gland malignancies and prognostic stratification based on a 20-year single institution experience.
Onderdonk BE; Vokes EE; Gwede M; Blair E; Agrawal N; Haraf DJ
Health Sci Rep; 2020 Dec; 3(4):e195. PubMed ID: 33043152
[TBL] [Abstract][Full Text] [Related]
14. Predictors for Salivary Gland Cancer Recurrence at Two Tertiary Hospitals in Saudi Arabia.
Alraddadi T; Aldhahri S; Alharbi J; Malas M; Islam T; Altuwaijri A; Al-Qahtani K
Cureus; 2019 Jul; 11(7):e5288. PubMed ID: 31576277
[TBL] [Abstract][Full Text] [Related]
15. Treatment Outcome of a Combined Dose-Escalated Treatment Regime With Helical TomoTherapy® and Active Raster-Scanning Carbon Ion Boost for Adenocarcinomas of the Head and Neck.
Akbaba S; Mock A; Hoerner-Rieber J; Held T; Katayama S; Forster T; Freudlsperger C; Rieken S; Herfarth K; Plinkert P; Debus J; Adeberg S
Front Oncol; 2019; 9():755. PubMed ID: 31475108
[No Abstract] [Full Text] [Related]
16. Patterns of treatment failure in salivary gland cancers.
Szewczyk M; Golusiński P; Pazdrowski J; Pieńkowski P; Marszałek S; Sygut J; Golusiński W
Rep Pract Oncol Radiother; 2018; 23(4):260-265. PubMed ID: 29991930
[TBL] [Abstract][Full Text] [Related]
17. Salivary gland carcinoma: Prediction of cancer death risk based on apparent diffusion coefficient histogram profiles.
Sumi M; Nakamura T
PLoS One; 2018; 13(7):e0200291. PubMed ID: 29975742
[TBL] [Abstract][Full Text] [Related]
18. Distant metastasis is a critical mode of failure for patients with localized major salivary gland tumors treated with surgery and radiation.
Tam M; Riaz N; Salgado LR; Spratt DE; Katsoulakis E; Ho A; Morris LGT; Wong R; Wolden S; Rao S; Lee N
J Radiat Oncol; 2013 Sep; 2(3):285-291. PubMed ID: 29152056
[TBL] [Abstract][Full Text] [Related]
19. Management of salivary gland carcinomas - a review.
Wang X; Luo Y; Li M; Yan H; Sun M; Fan T
Oncotarget; 2017 Jan; 8(3):3946-3956. PubMed ID: 27992367
[TBL] [Abstract][Full Text] [Related]
20. Radiation therapy in the treatment of minor salivary gland tumors.
Salgado LR; Spratt DE; Riaz N; Romesser PB; Wolden S; Rao S; Chin C; Hong JC; Wong R; Lee NY
Am J Clin Oncol; 2014 Oct; 37(5):492-7. PubMed ID: 23428950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
